Skip to main content

Table 2 Satisfaction with the monitoring frequency (n=1905)

From: Satisfaction of well-controlled type 2 diabetes patients with three-monthly and six-monthly monitoring

  Not satisfied n=171 Satisfied n=1734  
  n Mean ± SD or n (%) n Mean ± SD or n (%) P-value
Age at baseline 171 62.5 ± 8.9 1734 64.6 ± 8.6 0.003
Gender, male 171 111 (64.9%) 1734 1029 (59.3%) 0.156
One or more comorbidities at baseline 171 69 (40.4%) 1734 646 (37.3%) 0.425
Duration of diabetes (in years) 167 5.6 ± 3.3 1695 5.9 ± 3.7 0.283
Current smoker* 165 35 (21.2%) 1672 251 (15.0%) 0.137
SF-36 PCS [scale: 0–100]* 137 44.7 ± 10.4 1414 45.7 ± 10.5 0.027
SF-36 MCS [scale: 0–100]* 137 51.5 ± 10.5 1414 54.1 ± 8.7 0.407
EQ VAS [scale: 0–100]* 155 71.7 ± 13.8 1510 75.2 ± 14.7 0.100
PAID [scale: 0–80]* 152 10.3 ± 11.8 1539 6.5 ± 9.0 <0.001
DTSQ [scale: 0–36]* 158 26.8 ± 6.4 1607 32.4 ± 4.1 <0.001
DTSQ hyper [scale: 0–6]* 166 2.2 ± 1.9 1650 1.3 ± 1.7 <0.001
DTSQ hypo [scale: 0–6]* 166 1.3 ± 1.6 1652 0.8 ± 1.4 0.001
HbA1c (mmol/mol)** 160 49.3 ± 6.8 1656 48.2 ± 7.5 0.077
HDL cholesterol (mmol/l)** 159 1.2 ± 0.3 1637 1.2 ± 0.3 0.089
LDL cholesterol (mmol/l)** 159 2.4 ± 0.8 1634 2.3 ± 0.7 0.044
Total cholesterol (mmol/l)** 159 4.3 ± 0.9 1633 4.2 ± 0.8 0.069
Systolic blood pressure (mmHg)* 130 132.9 ± 15.1 1477 134.0 ± 14.7 0.680
Diastolic blood pressure (mmHg)* 130 78.1 ± 9.9 1474 76.3 ± 9.2 0.025
BMI (kg/m2)* 120 29.1 ± 4.2 1373 29.1 ± 4.8 0.609
  1. * Final measurement, corrected for baseline measurement.
  2. ** Last known measurement during follow-up.
  3. SF-36 Short-Form 36, PCS Physical Component Score, MCS Mental Component Score, EQ VAS EuroQol Visual Analogue Scale, PAID Problem Areas In Diabetes, DTSQ Diabetes Treatment Satisfaction Questionnaire status.